GSA Capital Partners’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $876K | Buy |
+21,628
| New | +$876K | 0.06% | 546 |
|
|
2024
Q4 | – | Sell |
-22,493
| Closed | -$740K | – | 2022 |
|
|
2024
Q3 | $740K | Buy |
+22,493
| New | +$740K | 0.06% | 655 |
|
|
2024
Q2 | – | Sell |
-5,738
| Closed | -$209K | – | 2018 |
|
|
2024
Q1 | $209K | Sell |
5,738
-13,228
| -70% | -$482K | 0.02% | 1396 |
|
|
2023
Q4 | $384K | Buy |
+18,966
| New | +$384K | 0.03% | 971 |
|